The investigators discuss their findings that demonstrate patients with previous radiotherapy experienced significantly longer PFS and OS with pembrolizumab treatment versus those with no previous radiotherapy.
Shawna T. Chan, BA
Articles by Shawna T. Chan, BA
Latest Updated Articles
Synergy of Radiotherapy and Anti-PD-1 Therapy With Pembrolizumab in NSCLC: Is This Perfect Harmony?Published: August 23rd 2017 | Updated: